Mandate

Vinge advises eEducation Albert AB (publ) in connection with the listing on Nasdaq First North Growth Market6 October 2021

Vinge has advised eEducation Albert AB (publ) (”Albert”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 21 September 2021 and the first day of trading occurred on 1 October 2021.

The offer in connection with the listing covered approximately 4 700 000 newly issued shares as well as an oversubscription option for a further total amount of approximately 700 000 shares. The shares were offered at a price of SEK 49 per share, which entails that the offer (in conjunction with full utilization of the oversubscription option) amounted to approximately SEK 264 million. The price corresponds to a market value for the company of approximately SEK 600 million prior to the implementation of the offer.

Albert, which was founded in 2015 and has its registered office in Gothenburg, is an app‑based educational platform for children in the age intervals between 3 and 16 and offers EdTech services on a subscription basis. Since Albert was founded, the company has helped more than 275 000 families with their children’s education.

Vinge’s team primarily consisted of Wibeke SorlingEdin AgicLinus AdolfssonHanna Jansson (Capital Markets and Public M&A), Anna Backman (Employment), Alexander LindbergAnna Högsten (IP/IT), Victor Ericsson and Emelie Svanberg (Tax).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025